Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
- [31] Yingjie Zhang , xuwenfang and 曹江营. Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as AminopeptidaseN (APN) Inhibitors. CHEMMEDCHEM, 13, 431, 2018.
- [32] xuwenfang , Yingjie Zhang and 臧杰. Development of N-hydroxycinnamamide-based HDAC inhibitors with improved HDAC inhibitory activity and in vitro antitumor activity. Bioorganic & medicinal chemistry, 25, 2666, 2017.
- [33] xuwenfang , Yingjie Zhang and 高帅. Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups. Bioorganic & medicinal chemistry, 25, 2981, 2017.
- [34] yangxinying , xuwenfang , Yingjie Zhang and 闫玉刚. Sulfoxide Analogs of TAK-875 as G Protein Coupled Receptor 40 Agonists: Synthesis, Determination of Absolute Configuration and Biological Activity. Chinese journal of organic chemistry, 37, 858, 2017.
- [35] xuwenfang , Yingjie Zhang , Wu Jingde and 李晓杨. Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 134, 185, 2017.
- [36] xuwenfang , Yingjie Zhang and zhounan. Discovery of a tetrahydroisoquinoline-based HDAC inhibitor with improved plasma stability. Bioorganic & medicinal chemistry, 25, 4614, 2017.
- [37] Yingjie Zhang. Discovery of a fluorescent probe with HDAC6 selective inhibition. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 141, 596, 2017.
- [38] xuwenfang , Yingjie Zhang and 高帅. Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy. Anti-cancer agents in medicinal chemistry, 17, 802, 2017.
- [39] Yingjie Zhang and xuwenfang. Nitric oxide donor hybrid compounds as promising anticancer agents. Drug Discov. Ther., 2016.
- [40] Yingjie Zhang and xuwenfang. Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold. Drug Des. Dev. Ther., 2015.